Otros idiomas Eli Lilly and Company

Acciones

LLY

US5324571083

Farmacéuticos

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 09/07/2025			Después del cierre 02:00:00
786,92 ^USD	+1,19 %		788,50	+0,20 %

09/07	Öhman Hälsa och Ny Teknik sube un 3,9% en junio; Camurus destaca tras acuerdo con Eli Lilly	FW
09/07	Eli Lilly Se Beneficia de Mayores Ventas de Zepbound en el Segundo Trimestre, Según BofA	MT

Otros idiomas

Sector Update: Health Care Stocks Higher Late Afternoon	09/07
Sector Update: Health Care	09/07
Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	09/07
Eli Lilly, Merck, Starbucks... Les valeurs à suivre aujourd'hui à Wall Street	09/07
USA-Les valeurs à suivre à Wall Street (actualisé)	09/07
Eli Lilly: new recommended dosage for Kisunla	09/07
Eli Lilly : nouveau schéma posologique pour un traitement de la maladie d'Alzheimer	09/07
Eli Lilly and Company Announces FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease	09/07
Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's	09/07
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	09/07
Eli Lilly FDA approves updated label for Kisunla	09/07
US FDA approves gradual dosing for Lilly Alzheimer's drug	09/07
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease	09/07
Trump says pharmaceutical tariffs could reach 200%	08/07
MÄRKTE USA/Trump verhindert Erholung der Börsen	08/07
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	08/07
WeightWatchers nomme une nouvelle directrice médicale, prépare un programme pour la ménopause	08/07
WeightWatchers names new medical chief, plans to offer menopause therapy and support	08/07
Sector Update: Tech	07/07
Alphabet's Isomorphic Labs Readying to Test AI-Designed Drugs on People	07/07
Demand for obesity drugs shoots up in India as Lilly, Novo vie for market share	07/07
Demand for obesity drugs shoots up in India as Lilly, Novo vie for market share	07/07
Novo Nordisk: hoe de Deen de Amerikaanse markt liet glippen	03/07
Novo Nordisk: come ha fatto a perdere sul mercato americano?	02/07
How Novo Nordisk misread the US market for its weight loss sensation	01/07

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Acciones

El consejero delegado de Eli Lilly habla de la lucha contra el cáncer y la obesidad, y del precio de los medicamentos

13 de enero 2025 a las 17:30